FDA moves toward easing restrictions on certain peptides BioPharma Dive FDA Targets GLP 1 and Peptide Compounding, Advertising and 'Research Use Only' Labeling How different peptide therapies may affect your body Prenuvo blog New: An FDA decision to place 19 peptides on the unsafe list was supported by numerous documented safety concerns, former officials said. Even though demand for peptide therapies has exploded since then, When will the FDA reclassify BPC 157 to Category 1 Octagon AI